Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Setting shapes the strain: Untangling alpha-synuclein heterogeneity.

Neural regeneration research·2026

Same author

Working with worldview differences in Aotearoa: a relational approach to Te Tiriti-based governance.

Journal of the Royal Society of New Zealand·2025

Same author

Rethinking 'rare' <i>PINK1</i> Parkinson's disease: A meta-analysis of geographical prevalence, phenotypic diversity, and α-synuclein pathology.

Journal of Parkinson's disease·2025

Same author

Refining α-synuclein seed amplification assays to distinguish Parkinson's disease from multiple system atrophy.

Translational neurodegeneration·2025

Same author

Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy.

Brain : a journal of neurology·2025

Same author

Enhanced detection of distinct honeycomb-structured neuronal SMARCC2 cytobodies in Parkinson's Disease via Cyclic Heat-Induced Epitope Retrieval (CHIER).

PloS one·2024

Search research articles

相关实验视频

Updated: Sep 16, 2025

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time

Published on: May 30, 2021

使用UltraID-LIPA捕获α-synuclein聚合反应器

Kreesan Reddy¹, Birger Victor Dieriks¹

¹Department of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand; Centre for Brain Research, University of Auckland, Auckland, 1023, New Zealand.

Trends in neurosciences

|July 11, 2025

概括

研究人员开发了UltraID光感应蛋白聚合 (UltraID-LIPA) 来研究细胞中早期α-synuclein聚合. 这种技术可以识别参与同核蛋白病变的初始阶段的关键蛋白质.

关键词:

帕金森病是帕金森氏症的一种疾病.疾病异质性疾病异质性蛋白质相互作用组的作用.蛋白质的错误折叠蛋白质的错误折叠菌株多样性菌株多样性合成核蛋白病变 (synucleinopathies) 是一种同核蛋白病变.

更多相关视频

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

相关实验视频

Last Updated: Sep 16, 2025

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time

Published on: May 30, 2021

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
生物化学生物化学

背景情况:

像帕金森病这样的同核蛋白病,以α-synuclein蛋白质的聚合为特征.
了解驱动α-synuclein聚合的早期分子事件对于开发有效疗法至关重要.

研究的目的:

开发一种用于可视化和捕捉活细胞中早期α-synuclein聚合事件的新技术.
在聚合的初始阶段识别与α-synuclein相互作用的蛋白质.

主要方法:

这项研究利用光遗传学诱导α-synuclein聚合.
基于近距离的蛋白质组学 (UltraID-LIPA) 用于捕获与聚合α-synuclein紧邻的相互作用蛋白质.
使用高分辨率成像分析活细胞中的聚合事件.

主要成果:

UltraID-LIPA系统成功地以高分辨率捕获了早期聚合事件.
该技术确定了几种已知和新型的内解体蛋白,在早期聚合期间与α-synuclein相互作用.
这意味着内溶性体路径在突核蛋白病变的早期病原发生过程中.

结论:

UltraID-LIPA提供了一个强大的框架,用于剖析同核蛋白病变中的早期致病机制.
这些发现为参与α-synuclein聚合初始阶段的分子参与者提供了新的见解.
这种技术可以指导未来的创新,了解和治疗同核蛋白病变.